Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
944.45
|
|
Change (%)
|
-1.85 (-0.20%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
935.15
-
956.70
|
|
52-Week Range (RS)
|
783.75
-
1,250.00
|
|
Beta (1 Year)
|
0.61
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Jubilant Pharmova to convene board meeting |
| Paras Defence and Space Technologies Ltd leads losers in 'A' group |
| Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter |
| Jubilant Pharmova slips after weak Q3 performance |
| Jubilant Pharmova to declare Quarterly Results |
| Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. |
| Board of Jubilant Pharmova approves grant of 1,506 stock options |
| Jubilant Pharmova consolidated net profit rises 17.02% in the September 2025 quarter |
| Jubilant Pharmova Ltd - Jubilant Pharmova Limited - Press Release |
| Jubilant Pharmova Ltd - Jubilant Pharmova Limited - Outcome of Board Meeting |
|
|
|
| Incoporation Year : 1978 |
| Chairman : Shyam S Bhartia |
| Ownership Group : Jubilant Bhartia |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs |
| Registered Office |
Jubilant Pharmova Ltd
Bhartiagram Gajraula,
,
Amroha,
Uttar Pradesh-244223 |
Phone:91-5924-267200
Fax:91-5924-4264895/96 |
| E-Mail : investors@jubl.com |
| URL : http://www.jubl.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
17-Apr-2026 |
911.60 |
3.60 |
| 1Month |
24-Mar-2026 |
859.10 |
9.93 |
| 3Month |
27-Jan-2026 |
939.75 |
0.50 |
| 6Month |
24-Oct-2025 |
1118.20 |
-15.54 |
| 1Year |
24-Apr-2025 |
953.10 |
-0.91 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Quant Small Cap Fund |
0.93 |
240.62 |
| Bandhan Small Cap Fund |
1.03 |
207.13 |
| Kotak Multicap Fund |
0.69 |
153.00 |
| Bandhan Focused Fund |
4.71 |
85.33 |
| Kotak Special Opportunites Fund |
4.24 |
52.25 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Divis Laboratories Ltd |
6,359.20 |
-0.31 |
7,077.70 |
5,637.50 |
168,816.78 |
| Acutaas Chemicals Ltd |
2,395.10 |
0.36 |
2,687.75 |
1,041.05 |
19,608.95 |
| Neuland Laboratories Ltd |
14,408.95 |
-3.61 |
19,748.40 |
10,598.05 |
18,486.52 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) |
301.05 |
0.00 |
0.00 |
0.00 |
4,858.77 |
| Gujarat Themis Biosyn Ltd |
360.25 |
11.55 |
479.45 |
225.75 |
3,925.47 |
|
|
|
|